Table 4.

Comparing outcome and supplementary treatment procedures between two groups

	KH	ADH	p value
Intravenous fluids	24 (82.8)	23 (74.2)	0.42
ACE inhibitors	1 (3.4)	6 (20.7)	0.10
IVIG	3 (10.3)	3 (10.3)	1
ICU admission	9 (30)	4 (12.5)	0.09
Oxygen therapy	23 (79.3)	27 (84.4)	0.61
Noninvasive ventilation	5 (17.2)	1 (3.1)	0.09
Invasive ventilation	6 (20)	1 (3.1)	0.05
Inotropes or vasopressors	24 (82.8)	23 (74.2)	0.42
ECMO	2 (6.7)	0 (0)	0.23
Prone position	1 (3.3)	0 (0)	0.48
Additional antiviral drugs	1 (3.3)	2(6.3)	1
Antibiotic	27 (90)	21 (65.6)	0.02
Corticosteroid	2 (6.7)	9 (28.1)	0.03
Plasma freeze	2 (6.7)	0 (0)	0.23
Actemra (Tocilizumab)	0 (0)	2 (6.3)	0.49
Hospitalization period (days)	7.10 ± 6.44	7.19 ± 4.63	0.95
Death	6 (20)	3 (9.4)	0.29

Abbreviations: ACE, angiotensin‐converting enzyme; ECMO, extracorporeal membrane oxygenation; IVIG, intravenous Immunoglobulin.